Fermenta Biotech Limited

Equities

FERMENTA

INE225B01021

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:53 2024-04-26 am EDT 5-day change 1st Jan Change
176.6 INR -2.86% Intraday chart for Fermenta Biotech Limited +4.10% +9.28%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Fermenta Biotech Sells Premises in Thane, India for INR136 Million MT
Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Fermenta Biotech Sells Land in Pune, India for INR448 Million MT
CARE Cuts Rating on Fermenta Biotech's Long-term Bank Financing to BBB; Outlook Negative MT
Fermenta Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Fermenta Biotech Limited Approves Dividend for the Financial Year Ended March 31, 2023, Payable on or Before October 10, 2023 CI
Fermenta Biotech Opens Premix Plant in Kullu, India MT
Fermenta Biotech Limited Announces Inauguration of Customized Premix Manufacturing Plant in Kullu, Himachal Pradesh CI
Fermenta Biotech Resumes Full Operations of Kullu Plant in Himachal Pradesh, India MT
Fermenta Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Fermenta Biotech Resumes Partial Operations at Himachal Pradesh, India Facility MT
Fermenta Biotech Halts Operations at Himachal Pradesh, India Facility Due to Heavy Rain MT
Fermenta Biotech Limited Announces Suspension of Operations Due to Heavy Rainfall in Himachal Pradesh CI
Fermenta Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Fermenta Biotech Limited Recommends Final Equity Dividend for the Financial Year Ended March 31, 2023 CI
Fermenta Biotech Sells Premises in Thane, India for INR66 Million MT
Fermenta Biotech Sells Property in Maharashtra, India for INR140.5 Million MT
Fermenta Biotech Sells Company Premises in Thane, India for INR140 Million MT
CARE Cuts Rating on Fermenta Biotech's Long-term Bank Financing to BBB+; Revises Outlook to Negative MT
Fermenta Biotech Signs Pact to Sell Premises in Thane, India for INR140 Million MT
Fermenta Biotech Sells Property in Maharashtra, India for INR 116 Million MT
Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Fermenta Biotech Sells Property in Maharashtra, India for INR139 Million MT
Red Brick It Support Services LLP acquired premises in Thane One Building from Fermenta Biotech Limited for Rs 138.85 million. CI
Chart Fermenta Biotech Limited
More charts
Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. The Company's segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. The Company has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and rodenticides. The Company provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, natural astaxanthin and vitamin AD2 premix, among others.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. FERMENTA Stock
  4. News Fermenta Biotech Limited
  5. CARE Cuts Rating on Fermenta Biotech's Long-term Bank Financing to BBB; Outlook Negative